Radioactive 125I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients

Table 1 Characteristics of pancreatic cancer patients with unexpected liver metastasis (n = 26)

Clinicopathologic feature	Value (%)
Mean age (range), yr	60.5 ± 9.7 (38-81)
Sex, M/F
Male	18 (69.2)
Female	8 (30.8)
Tumor location in the pancreas
Head	17 (65.4)
Neck and body	6 (23.2)
Tail	3 (11.5)
Vascular involvement
Any superior mesenteric vein	10 (38.5)
Any superior mesenteric artery	9 (34.6)
Both venous and arterial	8 (30.8)
Palliative operation	14 (53.8)
Choledochojejunostomy	11 (78.6)
Choledochojejunostomy and gastroenterostomy	3 (21.4)
Postoperative pain relief
Complete remission	5 (19.2)
Partial remission	17 (65.4)
No relief	4 (15.4)
PHS (d)	7.6 ± 2.8 (4-14)
EBL (mL)	148.3 ± 282.1 (5-1500)
Postoperative complications
Biliary fistula	1 (3.8)
Pancreatic fistula	1 (3.8)
Vital status at last follow-up
Alive	3 (11.5)
Dead	23 (88.5%)
Median overall survival (range), mo	10.0 (1-27)

PHS: Postoperative hospital stay; EBL: Estimated blood loss.

Table 2 Baseline data of patients from the two groups (n = 26)

Clinicopathologic feature	Non-chemotherapy (n = 19)	Chemotherapy (n = 7)	P value
Mean age (rang), yr	60.74 (38-81)	59.86 (48-70)	0.841
Sex, M/F			0.715
Male	14	4
Female	5	3
Tumor location in the pancreas			1.000
Head	12	5
Neck and body	5	1
Tail	2	1
Palliative operation			0.505
Choledochojejunostomy	8	3
Choledochojejunostomy and gastroenterostomy	1	2
1-yr survival rate (%)	15.8	68.6	0.012